1. Home
  2. EIC vs JUNS Comparison

EIC vs JUNS Comparison

Compare EIC & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EIC
  • JUNS
  • Stock Information
  • Founded
  • EIC N/A
  • JUNS 2015
  • Country
  • EIC United States
  • JUNS United States
  • Employees
  • EIC N/A
  • JUNS N/A
  • Industry
  • EIC Finance/Investors Services
  • JUNS
  • Sector
  • EIC Finance
  • JUNS
  • Exchange
  • EIC Nasdaq
  • JUNS NYSE
  • Market Cap
  • EIC 287.1M
  • JUNS 281.4M
  • IPO Year
  • EIC 2019
  • JUNS 2024
  • Fundamental
  • Price
  • EIC $15.65
  • JUNS $5.42
  • Analyst Decision
  • EIC
  • JUNS
  • Analyst Count
  • EIC 0
  • JUNS 0
  • Target Price
  • EIC N/A
  • JUNS N/A
  • AVG Volume (30 Days)
  • EIC 116.0K
  • JUNS 494.3K
  • Earning Date
  • EIC 11-14-2023
  • JUNS 02-11-2025
  • Dividend Yield
  • EIC 13.63%
  • JUNS N/A
  • EPS Growth
  • EIC N/A
  • JUNS N/A
  • EPS
  • EIC 0.80
  • JUNS N/A
  • Revenue
  • EIC N/A
  • JUNS N/A
  • Revenue This Year
  • EIC N/A
  • JUNS N/A
  • Revenue Next Year
  • EIC N/A
  • JUNS N/A
  • P/E Ratio
  • EIC $20.31
  • JUNS N/A
  • Revenue Growth
  • EIC N/A
  • JUNS N/A
  • 52 Week Low
  • EIC $13.00
  • JUNS $3.86
  • 52 Week High
  • EIC $16.48
  • JUNS $19.51
  • Technical
  • Relative Strength Index (RSI)
  • EIC 46.33
  • JUNS N/A
  • Support Level
  • EIC $15.76
  • JUNS N/A
  • Resistance Level
  • EIC $15.93
  • JUNS N/A
  • Average True Range (ATR)
  • EIC 0.20
  • JUNS 0.00
  • MACD
  • EIC -0.01
  • JUNS 0.00
  • Stochastic Oscillator
  • EIC 32.11
  • JUNS 0.00

About EIC Eagle Point Income Company Inc.

Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation.

About JUNS JUPITER NEUROSCIENCES INC

Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.

Share on Social Networks: